GMED vs TFX: stock comparison and AI forecast
Globus Medical Inc (GMED) and Teleflex Inc (TFX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GMED Globus Medical Inc
- Market Cap
- $10.93B
- P/E Ratio
- 17.7x
- Size
- large-cap
- AI Forecast
TFX Teleflex Inc
- Price
- $152.15 +23.5% · 6M
- Market Cap
- $6.45B
- P/E Ratio
- 17.5x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GMED is 1.7 times larger than TFX by market capitalization ($10.93B against $6.45B).
- TFX trades at 17.5 times trailing earnings, GMED at 17.7 times.
- TFX carries 0.82 times debt per unit of equity, against 0.11 times for GMED.
- TFX yields 0.91% in dividends; GMED pays none.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GMED | TFX |
|---|---|---|
| Market Cap | $10.93B | $6.45B |
| P/E Ratio | 17.74x | 17.47x |
| P/B Ratio | 5.51x | 1.85x |
| Dividend Yield | – | 0.91% |
| EPS | $4.59 | $8.71 |
| Book Value/Share | $14.79 | $82.45 |
| Revenue/Share | $23.38 | $30.31 |
| FCF/Share | $5.71 | $9.16 |
Profitability & Margins
| Metric | GMED | TFX |
|---|---|---|
| ROE | – | 8.7% |
| ROA | – | 4.8% |
| ROIC | – | 8.2% |
| Gross Margin | 69.1% | 66.7% |
| Operating Margin | 58.3% | 34.6% |
| Net Margin | – | 23.7% |
| EBT Margin | 60.0% | 26.7% |
| Tax Rate | 20.3% | 0.7% |
Financial Health
| Metric | GMED | TFX |
|---|---|---|
| Current Ratio | 4.30x | 2.01x |
| Quick Ratio | 2.67x | 1.59x |
| D/E Ratio | 0.11x | 0.82x |
| Financial Leverage | – | 1.82x |
| Interest Coverage | 35.9x | 2.1x |
| Working Capital | $1.67B | $928M |
Cash Flow
| Metric | GMED | TFX |
|---|---|---|
| Operating Cash Flow | $926M | $443M |
| Free Cash Flow | $767M | $388M |
| Capital Spending | -$159M | -$55M |
| OCF Growth YoY | 29.5% | 13.4% |
| FCF Growth YoY | 32.2% | 46.9% |
| FCF/Sales | 24.4% | 30.2% |
| CapEx/Sales | 5.1% | 4.3% |
Operational Efficiency
| Metric | GMED | TFX |
|---|---|---|
| Asset Turnover | – | 0.20x |
| Receivables Turnover | 4.7x | 3.4x |
| Inventory Turnover | 1.2x | 1.1x |
| Fixed Assets Turnover | 5.9x | 2.7x |
| Days Sales Outstanding | 79 days | 108 days |
| Days Inventory | 310 days | 328 days |
| Payables Period | 40 days | 122 days |
| Cash Conversion Cycle | 348 days | 314 days |
Income Statement
| Metric | GMED | TFX |
|---|---|---|
| Total Revenue | $3.14B | $1.28B |
| Operating Income | $680M | $445M |
| Net Income | – | $305M |
| R&D Expense | $144M | $145M |
| SG&A Expense | $1.19B | $661M |
| Cost of Goods Sold | $970M | $428M |
Dividend & Shareholder Information
| Metric | GMED | TFX |
|---|---|---|
| Dividends Per Share | – | $1.39 |
| Payout Ratio | – | 16.0% |
| Shares Outstanding | 134M | 42M |
| EPS Growth | 67.5% | – |
GMED vs TFX: stock comparison and AI forecast
Which is bigger, GMED or TFX?
GMED is 1.7 times larger than TFX by market capitalization ($10.93B against $6.45B).
Which is cheaper on earnings, GMED or TFX?
TFX trades at 17.5 times trailing earnings, GMED at 17.7 times.
Which one does Intratio's AI model rank higher, GMED or TFX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.